| 2003 | 2000 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Used 1 of 33 inappropriate drugs | Used 1 of 11 drugs that should be avoided | Used 1 of 33 inappropriate drugs | Used 1 of 11 drugs that should be avoided | ||||||
| Population group | Percent | Standard error | Percent | Standard error | Percent | Standard error | Percent | Standard error | |
| Total | 18.7 | 0.8 | 3.1 | 0.37 | 19.1 | 0.9 | 3.3 | 0.4 | |
| Racea | White only | 18.6 | 0.9 | 3.3 | 0.4 | -- | -- | -- | -- |
| Black only | 17.4 | 2.0 | 1.7 | 0.6 | -- | -- | -- | -- | |
| AI/AN only | DSU | DSU | DSU | DSU | -- | -- | -- | -- | |
| Asian only | DSU | DSU | DSU | DSU | -- | -- | -- | -- | |
| NHOPI only | DSU | DSU | DSU | DSU | -- | -- | -- | -- | |
| Multiple races | DSU | DSU | DSU | DSU | -- | -- | -- | -- | |
| Ethnicityb | Hispanic, all races | 13.2 | 1.7 | 2.8 | 0.7 | 19.3 | 2.6 | 4.1 | 1.2 |
| Non-Hispanic, all races | 18.7 | 0.8 | 3.1 | 0.4 | 19.1 | 0.9 | 3.3 | 0.4 | |
| Non-Hispanic, White | 18.9 | 0.9 | 3.4 | 0.4 | 19.3 | 1.0 | 3.6 | 0.4 | |
| Non-Hispanic, Black | 17.6 | 2.0 | 1.7 | 0.6 | 18.7 | 2.3 | 1.4 | 0.7 | |
| Non-Hispanic, other | 16.1 | 3.4 | 1.7 | 1.3 | 13.6 | 8.5 | DSU | DSU | |
| Gender | Male | 13.3 | 0.9 | 1.7 | 0.4 | 16.4 | 1.4 | 2.8 | 0.6 |
| Female | 22.2 | 1.1 | 4.2 | 0.5 | 21.2 | 0.9 | 3.8 | 0.5 | |
| Age | 65-69 | 18.4 | 1.6 | 4.3 | 0.9 | 17.5 | 1.9 | 3.2 | 0.8 |
| 70-74 | 19.0 | 1.5 | 2.7 | 0.6 | 21.6 | 1.6 | 3.9 | 0.8 | |
| 75-79 | 17.2 | 1.6 | 2.8 | 0.7 | 17.4 | 1.8 | 3.2 | 1.0 | |
| 80-84 | 18.5 | 2.2 | 3.1 | 0.9 | 19.2 | 2.3 | 3.4 | 0.9 | |
| 85 and over | 18.6 | 2.3 | 2.0 | 0.8 | 21.0 | 2.9 | 2.6 | 1.2 | |
| Educationc | Less than high school | 19.2 | 1.2 | 3.0 | 0.5 | 22.2 | 1.8 | 3.5 | 0.7 |
| High school graduate | 19.5 | 1.5 | 3.3 | 0.6 | 17.3 | 1.5 | 2.9 | 0.6 | |
| At least some college | 16.7 | 1.3 | 3.0 | 0.6 | 18.1 | 1.5 | 3.8 | 0.8 | |
| Insurance | Medicare only | 16.8 | 1.2 | 1.5 | 0.4 | 17.8 | 1.5 | 4.0 | 0.7 |
| Medicare and private | 19.0 | 1.2 | 3.9 | 0.5 | 18.1 | 1.1 | 2.8 | 0.5 | |
| Medicare and other public | 19.7 | 1.9 | 3.0 | 0.9 | 28.5 | 3.0 | 4.2 | 0.9 | |
| Family incomed | Negative/poor | 18.4 | 1.7 | 3.7 | 0.9 | 21.5 | 1.9 | 1.9 | 0.6 |
| Near poor/low | 18.3 | 1.2 | 2.0 | 0.5 | 20.9 | 1.7 | 4.3 | 0.9 | |
| Middle | 19.6 | 1.3 | 3.7 | 0.8 | 18.9 | 1.6 | 3.3 | 0.7 | |
| High | 17.1 | 1.4 | 3.4 | 0.7 | 16.8 | 1.4 | 3.0 | 0.8 | |
| Residence locatione | Metropolitan-large | 16.7 | 1.1 | 2.4 | 0.5 | 15.2 | 1.2 | 2.6 | 0.5 |
| Metropolitan-small | 19.3 | 1.5 | 4.0 | 0.8 | 23.5 | 1.7 | 5.2 | 0.6 | |
| Micropolitan | 21.3 | 2.5 | 3.8 | 1.1 | 19.7 | 2.4 | 2.4 | 0.7 | |
| Noncore | 19.3 | 2.6 | 2.5 | 1.0 | 24.8 | 2.2 | 2.4 | 1.0 | |
| Perceived health status | Excellent/very good/good | 16.1 | 0.9 | 3.1 | 0.4 | 15.8 | 1.0 | 2.5 | 0.3 |
| Fair/poor | 26.9 | 1.7 | 3.3 | 0.7 | 30.2 | 1.9 | 6.2 | 1.1 | |
a Prior to 2002, racial categories were not directly comparable to those used for 2002 or later years' data; thus, race data for 2000 are not shown.
b Beginning in 2002, individuals could report multiple races. For 2002 and later years, Non-Hispanic categories exclude multiple-race individuals and are not directly comparable to data from previous years.
c Less than high school refers to fewer than 12 years of education; high school graduatE, 12 years of education; and at least some college, more than 12 years of education.
d Negative/poor refers to household incomes below the Federal poverty line; near poor/low, over the poverty line to just below 200 percent of the poverty line; middle, 200 percent to just below 400 percent of the poverty line; and high, 400 percent of the poverty line and over.
e See the MEPS entry in the Data Sources section of the Measures Specifications Appendix for more information.
DSU - Data do not meet the criteria for statistical reliability, data quality or confidentiality.
-- Data not shown. See footnote a.
Key: AI/AN: American Indian or Alaska Native; NHOPI: Native Hawaiian or Other Pacific Islander.
Source:Agency for Healthcare Research and Quality, Center for Financing, Access and Cost Trends, Medical Expenditure Panel Survey.